Endocrine Abstracts

Thyroid cancer is frequently treated by surgery, followed by administration of radioiodide, an ablative treatment utilising high energy beta-emitting 131I. Given that the sodium iodide symporter (NIS) is the sole transporter of iodide into human cells, and is expressed predominantly in the thyroid, 131I therapy selectively targets post-surgical thyroid remnants and metastases, markedly improving outcome and survival. Radioiodine therapy is thus a safe, sp...